MendaCel, Inc
MendaCel, Inc is pioneering the future of wound care with its proprietary device, MendaCel™, which integrates proven treatment modalities into a dynamic delivery system for at-home care. The company is advancing its innovative solutions with patent-pending technology, verified manufacturability, and regulatory exemptions. MendaCel is actively engaged in funding and partnership opportunities, including a successful NIH Phase 1 SBIR/STTR application and a pending US Army MRDC BAA pre-application.
What We Do
A proprietary wound care device that combines proven treatment modalities into a dynamic delivery system for at-home wound care. It is patent-pending, with working prototypes and is FDA 510(k) exempt.
Regenerative Medicine
Key People
Inventor
News & Updates
MendaCel will be exhibiting at Med-Tech World Malta in November 2024.
MendaCel will be virtually attending the Boston RESI conference in September 2024.
An article discussing MendaCel's introduction of a cutting-edge wound care device.